Who owns Kura Oncology, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of KURA from SEC Form 13F filings across 233 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 233 institutions disclosed 88.8M shares of Kura Oncology, Inc. worth $950.2M — about 98.9% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
233
13F holders
$950.2M
value, 2026 filers
98.9%
of shares outstanding (88.8M sh)
41
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of KURA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 11.8M | $125.9M | 0.0% | 13.1% | +11.9% |
| 2 | MONTANOVA CAPITAL, LLC | 7.9M | $84.6M | 2.0% | 8.8% | -7.9% |
| 3 | BVF INC/IL | 6.7M | $71.7M | 2.4% | 7.4% | -20.8% |
| 4 | STATE STREET CORP | 4.7M | $50.4M | 0.0% | 5.2% | -11.6% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 3.9M | $41.8M | 0.0% | 4.3% | -0.4% |
| 6 | AQR CAPITAL MANAGEMENT LLC | 3.7M | $39.5M | 0.0% | 4.1% | +18.0% |
| 7 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.8M | $29.5M | 0.0% | 3.1% | +95.1% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.3M | $24.6M | 0.0% | 2.6% | +2.9% |
| 9 | ALETHEA CAPITAL MANAGEMENT, LLC | 2.2M | $23.3M | 11.9% | 2.4% | +0.4% |
| 10 | ARMISTICE CAPITAL, LLC | 2.1M | $22.4M | 0.3% | 2.3% | -43.0% |
| 11 | RENAISSANCE TECHNOLOGIES LLC | 2.0M | $21.5M | 0.0% | 2.2% | +20.5% |
| 12 | GOLDMAN SACHS GROUP INC | 2.0M | $21.2M | 0.0% | 2.2% | -12.4% |
| 13 | JACOBS LEVY EQUITY MANAGEMENT, INC | 1.9M | $20.6M | 0.1% | 2.1% | +102.4% |
| 14 | Qube Research & Technologies Ltd | 1.8M | $19.8M | 0.0% | 2.1% | +58.0% |
| 15 | BANK OF AMERICA CORP /DE/ | 1.5M | $15.8M | 0.0% | 1.6% | +26.8% |
| 16 | JUPITER ASSET MANAGEMENT LTD | 1.5M | $15.7M | 0.1% | 1.6% | +188.0% |
| 17 | ALGERT GLOBAL LLCNEW | 1.3M | $14.0M | 0.2% | 1.5% | new |
| 18 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.3M | $13.9M | 0.0% | 1.4% | -2.4% |
| 19 | Prosight Management, LP | 1.3M | $13.7M | 2.6% | 1.4% | -36.9% |
| 20 | HRT FINANCIAL LP | 1.2M | $12.8M | 0.0% | 1.3% | +457.2% |
| 21 | NAN FUNG TRINITY (HK) LTD | 1.2M | $12.6M | 1.2% | 1.3% | 0.0% |
| 22 | Connor, Clark & Lunn Investment Management Ltd. | 1.1M | $12.0M | 0.0% | 1.3% | +12.9% |
| 23 | MORGAN STANLEY | 957,240 | $10.3M | 0.0% | 1.1% | -17.5% |
| 24 | UBS Group AG | 925,401 | $9.9M | 0.0% | 1% | -4.1% |
| 25 | TWO SIGMA INVESTMENTS, LP | 864,401 | $9.3M | 0.0% | 1% | +415.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.